Chemspeed has created a vast range of solutions for an unrivaled range of workflows / applications and industries based on our off-the-shelf design, scalable modularity and flexibility. These solutions serve as great examples of what is achievable using our technologies - the possibilities for your workflows are almost limitless.
Gravimetric pick & decision dispense of solids (matrix-to-matrix) - paradigm shift in solid / powder distribution / reformatting.
Step-change in end-to-end DSC sample preparation - gravimetric pick & decision dispense of solids / matrix-to-matrix reformatting.
Step-change in end-to-end NMR and LCMS sample preparation - gravimetric pick & decision dispense of solids / matrix-to-matrix reformatting (incl. applications in GMP environments).
Paradigm shift in catalyst screening - gravimetric pick & dispense of ligands, catalyst precursors, catalysts.
Are you looking for a configurable system to fit your exact workflows, an off-the-shelf product for a standard process, a GxP solution, and / or holistic lab software? Explore Chemspeed’s technologies to find the right fit for your needs.
Chemspeed is the leading provider of high throughput and high output research & development and quality control workflow solutions - from single bench-top / standalone automated workstations to fully automated, integrated, partial / entire product development workflows across a wide range of industries.
We’re scientists at heart - we know what scientists need and we design our systems with this deep understanding at the core of each project.
A statistically driven, automated approach to optimize glucose transformations to platform chemicals, methyl lactate and levulinic acid, is reported.
Self-driving laboratories (SDLs) promise an accelerated application of the scientific method. Through the automation of experimental workflows, along with autonomous experimental planning, SDLs hold the potential to greatly accelerate research in chemistry and materials discovery.
High-throughput experimentation (HTE) has become integral to the pharmaceutical industry with most major pharmaceutical companies investing in automation and high-throughput screening technologies.